Recap: Itamar Medical Q4 Earnings

 

Shares of Itamar Medical ITMR remained unaffected after the company reported Q4 results.

Quarterly Results

Earnings per share fell 400.00% over the past year to ($0.15), which missed the estimate of ($0.13).

Revenue of $12,772,000 rose by 30.79% year over year, which beat the estimate of $12,300,000.

Guidance

The upcoming fiscal year's revenue expected to be between $52,000,000 and $53,000,000.

Details Of The Call

Date: Mar 02, 2021

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/s5e4jez2

Recent Stock Performance

Company's 52-week high was at $29.00

Company's 52-week low was at $7.82

Price action over last quarter: Up 31.99%

Company Description

Itamar Medical Ltd engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardiological conditions and sleeps breathing disorders. It offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, a mobile device for convenient home use in the diagnoses of sleep breathing disorders; and EndoPAT device that diagnoses endothelial dysfunction. Geographically, it derives a majority of revenue from the United States and Canada.

Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...